The Korea University Medical Center is a collection of several hospitals, as well as the College of Medicine and College of Nursing associated with Korea University in Seoul, South Korea.

During the past decade, Korea University Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Korea University Medical Center" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Boston Scientific Corporation" with 2 trials sponsored, "Chong Kun Dang Pharmaceutical" with 2 trials sponsored, "LG Life Sciences" with 2 trials sponsored and "Ajou University School of Medicine" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Korea University Medical Center" #1 collaborator was "Korea Medical Device Development Fund" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "University of Rochester" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Korea University Medical Center" are "Chronic Hepatitis B" (3 trials), "Hypertension" (2 trials), "Carcinoma, Non Small Cell Lung" (1 trials), "Chronic Renal Disease" (1 trials) and "Congestive Heart Failure" (1 trials). Many other conditions were trialed in "Korea University Medical Center" in a lesser frequency.

Most popular intervention types in "Korea University Medical Center" are "Drug" (9 trials), "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Boston Scientific Open Irrigated Ablation Catheters" (1 trials), "CKD-519 100mg" (1 trials), "CKD-519 100mg 1Cap." (1 trials), "CKD-519 100mg 1Tab." (1 trials) and "CKD-519 200mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Korea University Medical Center" are 11 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Korea University Medical Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Korea University Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Korea University Medical Center, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

Korea University Medical Center has several departments that took part in Clinical trials: "Korea University Anam Hospital; Oncology Haemotology" - 4 trials, "Department of Urology, Korea University Anam Hospital" - 2 trials, "Korea University Anam Hospital" - 2 trials, "Department of Anaesthesiology and Pain Medicine, Korea University Guro Hospital" - 2 trials, "Department of Endocrinology and Metabolism, Korea University Ansan Hospital" - 2 trials